◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...

Aptose Biosciences Inc.

Financial Statements (IFRS) · Amounts in CAD
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line Item FY 2024Dec 31, 2024 FY 2023Dec 31, 2023 FY 2022Dec 31, 2022 FY 2021Dec 31, 2021
Total Revenue 0.00 0.00 0.00 0.00
Operating Revenue 0.00 0.00 0.00 0.00
Selling General And Administration 11.1M 15.5M 14.4M 19.3M
General And Administrative Expense 11.1M 15.5M 14.4M 19.3M
Research And Development 15.1M 36.8M 28.1M 46.0M
Depreciation And Amortization In Income Statement 19,000 49,000 81,000 138,000
Operating Expense 26.3M 52.4M 42.6M 65.4M
Operating Income -26.3M -52.4M -42.6M -65.4M
EBIT -25.2M -51.2M -42.6M -65.4M
Interest Expense 207,000 0.00 -- --
Interest Expense Non Operating 207,000 0.00 -- --
Interest Income 357,000 1.2M 788,000 94,000
Interest Income Non Operating 357,000 1.2M 788,000 94,000
Net Interest Income 150,000 1.2M 788,000 94,000
Other Income Expense 677,000 -2,000 -9,000 -1,000
Gain On Sale Of Security 677,000 -2,000 -9,000 -1,000
Pretax Income -25.4M -51.2M -41.8M -65.4M
Tax Effect Of Unusual Items 0.00 0.00 0.00 0.00
Net Income From Continuing And Discontinued Operation -25.4M -51.2M -41.8M -65.4M
Net Income From Continuing Operation Net Minority Interest -25.4M -51.2M -41.8M -65.4M
Net Income Including Noncontrolling Interests -25.4M -51.2M -41.8M -65.4M
Net Income Common Stockholders -25.4M -51.2M -41.8M -65.4M
Net Income -25.4M -51.2M -41.8M -65.4M
EBITDA -24.8M -50.7M -42.1M -64.8M
Normalized EBITDA -25.5M -50.7M -42.1M -64.8M
Reconciled Depreciation 404,000 466,000 528,000 622,000
Basic EPS -36.38 -227.43 -204.00 -328.50
Diluted EPS -36.38 -227.43 -204.00 -328.50
Basic Average Shares 698,979 225,154 205,033 197,968
Diluted Average Shares 698,979 225,154 205,033 197,968
Total Unusual Items 677,000 -2,000 -9,000 -1,000
Total Unusual Items Excluding Goodwill 677,000 -2,000 -9,000 -1,000
Tax Rate For Calcs 0.00 0.00 0.00 0.00
Normalized Income -26.1M -51.2M -41.8M -65.4M
Depreciation Amortization Depletion Income Statement 19,000 49,000 81,000 138,000
Depreciation Income Statement 19,000 49,000 81,000 138,000
Diluted NI Availto Com Stockholders -25.4M -51.2M -41.8M -65.4M
Net Income Continuous Operations -25.4M -51.2M -41.8M -65.4M
Net Non Operating Interest Income Expense 150,000 1.2M 788,000 94,000
Other Gand A 10.4M 13.3M 11.4M 10.2M
Salaries And Wages 714,000 2.3M 3.0M 9.2M
Total Expenses 26.3M 52.4M 42.6M 65.4M
Line Item FY 2024Dec 31, 2024 FY 2023Dec 31, 2023 FY 2022Dec 31, 2022 FY 2021Dec 31, 2021
Cash And Cash Equivalents 6.2M 9.3M 37.0M 39.1M
Cash Cash Equivalents And Short Term Investments 6.2M 9.3M 47.0M 79.1M
Cash Equivalents 4.6M 6.5M 36.4M 38.8M
Cash Financial 1.5M 2.8M 596,000 294,000
Other Short Term Investments -- 0.00 10.0M 40.0M
Prepaid Assets 2.3M 2.0M 2.3M 2.5M
Other Current Assets 570,000 600,000 257,000 133,000
Current Assets 9.5M 11.9M 49.5M 81.7M
Gross PPE 3.7M 3.9M 4.0M 3.0M
Accumulated Depreciation -3.1M -2.8M -2.5M -2.2M
Net PPE 597,000 1.1M 1.5M 788,000
Total Non Current Assets 597,000 1.1M 1.5M 788,000
Total Assets 10.1M 13.0M 51.0M 82.5M
Current Debt And Capital Lease Obligation 428,000 394,000 301,000 459,000
Accounts Payable 1.3M 3.5M 3.3M 1.7M
Payables 1.3M 6.0M 6.3M 1.7M
Payables And Accrued Expenses 4.0M 14.9M 12.0M 7.7M
Current Accrued Expenses 2.8M 8.8M 5.7M 6.0M
Current Liabilities 4.5M 15.3M 12.3M 8.2M
Long Term Debt 10.0M -- -- --
Long Term Debt And Capital Lease Obligation 10.2M 621,000 1.0M 115,000
Long Term Capital Lease Obligation 193,000 621,000 1.0M 115,000
Total Non Current Liabilities Net Minority Interest 10.2M 621,000 1.0M 115,000
Total Liabilities Net Minority Interest 14.7M 15.9M 13.3M 8.3M
Common Stock 457.4M 444.8M 437.5M 437.4M
Capital Stock 457.4M 444.8M 437.5M 437.4M
Additional Paid In Capital 83.3M 72.1M 68.9M 63.7M
Retained Earnings -541.0M -515.5M -464.3M -422.5M
Gains Losses Not Affecting Retained Earnings -4.3M -4.3M -4.3M -4.3M
Other Equity Adjustments -4.3M -4.3M -4.3M -4.3M
Common Stock Equity -4.5M -2.9M 37.7M 74.2M
Stockholders Equity -4.5M -2.9M 37.7M 74.2M
Total Equity Gross Minority Interest -4.5M -2.9M 37.7M 74.2M
Total Capitalization 5.5M -2.9M 37.7M 74.2M
Net Tangible Assets -4.5M -2.9M 37.7M 74.2M
Tangible Book Value -4.5M -2.9M 37.7M 74.2M
Working Capital 5.1M -3.4M 37.2M 73.6M
Invested Capital 5.5M -2.9M 37.7M 74.2M
Total Debt 10.6M 1.0M 1.3M 574,000
Net Debt 3.9M -- -- --
Share Issued 2.0M 264,745 205,260 204,922
Ordinary Shares Number 2.0M 264,745 205,260 204,922
Capital Lease Obligations 621,000 1.0M 1.3M 574,000
Current Capital Lease Obligation 428,000 394,000 301,000 459,000
Dueto Related Parties Current 0.00 2.6M 3.0M --
Leases 171,000 213,000 184,000 184,000
Machinery Furniture Equipment 373,000 391,000 560,000 560,000
Other Properties 3.1M 3.3M 3.3M 2.2M
Properties 0.00 0.00 0.00 0.00
Restricted Cash 555,000 0.00 -- --
Treasury Shares Number -- 0.00 -- --
Line Item FY 2024Dec 31, 2024 FY 2023Dec 31, 2023 FY 2022Dec 31, 2022 FY 2021Dec 31, 2021
Operating Cash Flow -36.0M -44.6M -32.3M -43.3M
Cash Flow From Continuing Operating Activities -36.0M -44.6M -32.3M -43.3M
Depreciation And Amortization 404,000 466,000 528,000 622,000
Depreciation Amortization Depletion 404,000 466,000 528,000 622,000
Stock Based Compensation 1.1M 3.7M 5.2M 12.9M
Change In Working Capital -11.0M 2.8M 4.3M 1.5M
Change In Payables And Accrued Expense -10.8M 2.9M 4.3M 1.4M
Change In Payable -4.8M -280,000 7.6M -472,000
Change In Other Current Assets 30,000 -343,000 -124,000 -4,000
Other Non Cash Items -376,000 -312,000 -571,000 7.0M
Capital Expenditure -5,000 -29,000 -24,000 -212,000
Purchase Of PPE -5,000 -29,000 -24,000 -212,000
Net PPE Purchase And Sale 18,000 -29,000 -24,000 -212,000
Purchase Of Investment -- -- -- -35.0M
Sale Of Investment 0.00 10.0M -- --
Net Investment Purchase And Sale 0.00 10.0M 30.1M -35.0M
Investing Cash Flow 18,000 10.0M 30.1M -35.2M
Cash Flow From Continuing Investing Activities 18,000 10.0M 30.1M -35.2M
Issuance Of Debt 10.0M 0.00 -- --
Net Issuance Payments Of Debt 10.0M 0.00 -- --
Issuance Of Capital Stock 23.4M 6.9M 101,000 36,000
Repurchase Of Capital Stock -21,000 -- -- --
Net Common Stock Issuance 23.4M 6.9M 101,000 36,000
Common Stock Payments -21,000 -- -- --
Financing Cash Flow 33.4M 6.9M 116,000 226,000
Cash Flow From Continuing Financing Activities 33.4M 6.9M 116,000 226,000
Effect Of Exchange Rate Changes 0.00 2,000 -4,000 7,000
Changes In Cash -2.5M -27.7M -2.1M -78.3M
Beginning Cash Position 9.3M 37.0M 39.1M 117.4M
End Cash Position 6.7M 9.3M 37.0M 39.1M
Free Cash Flow -36.0M -44.6M -32.3M -43.5M
Change In Account Payable -4.8M -280,000 7.6M -472,000
Change In Accrued Expense -6.1M 3.2M -3.3M 1.9M
Change In Prepaid Assets -211,000 261,000 173,000 78,000
Common Stock Issuance 23.4M 6.9M 101,000 36,000
Depreciation 404,000 466,000 528,000 622,000
Gain Loss On Investment Securities -686,000 -- -- --
Gain Loss On Sale Of PPE 76,000 0.00 16,000 0.00
Long Term Debt Issuance 10.0M 0.00 -- --
Net Foreign Currency Exchange Gain Loss -- 0.00 4,000 -7,000
Net Income From Continuing Operations -25.4M -51.2M -41.8M -65.4M
Net Long Term Debt Issuance 10.0M 0.00 -- --
Operating Gains Losses -610,000 -- 20,000 -7,000
Proceeds From Stock Option Exercised 28,000 29,000 15,000 190,000
Sale Of PPE 23,000 0.00 -- --
NEWS
Loading news...
TRENDING
Loading...